Company news

Bayer AG news in 2026

Bayer AG's news releases, calls and decks from 2026, newest first.

View company

ASCO 2026: Bayer to Present New Data Across Oncology Portfolio

May 21, 2026

Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease

May 21, 2026

Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

May 19, 2026

Bayer: FDA grants sevabertinib Priority Review as a first-line treatment for patients with HER2-mutant non-small cell lung cancer

May 18, 2026

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

May 15, 2026

Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities

May 13, 2026

Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026

May 12, 2026

Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

May 7, 2026

Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels

May 6, 2026

Bayer AG Successfully Migrates to Broadridge Swift Service Bureau, Strengthening Global Payment Infrastructure

May 6, 2026

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

May 6, 2026

Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

April 29, 2026

AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease

April 20, 2026

Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class

April 15, 2026

Soil Management Market Is Going to Boom – Growth Opportunities Through 2033 | Bayer Crop Science AG, Novozymes

April 13, 2026

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

April 1, 2026

National Advertising Division Recommends Bayer Modify or Discontinue Certain One A Day Men’s Pre-Conception Health Complete Multivitamin Claims

March 31, 2026

Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

March 31, 2026

Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative

March 26, 2026

Bayer Crop Science Launches 2026 Opportunity Scholarship Program

March 16, 2026

KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

March 16, 2026

NurExone Announces Corporate Updates

March 11, 2026

Missouri Court Grants Preliminary Approval of Roundup™ Class Settlement to Resolve Current and Future Claims

March 4, 2026

New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

March 4, 2026

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

February 27, 2026

Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases

February 26, 2026

Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA

February 23, 2026

Bayer, John Deere Further Integrate FieldView and Operations Center to Improve Customer Experience for 2026 Season

February 23, 2026

Monsanto Announces Roundup™ Class Settlement Agreement to Resolve Current and Future Claims

February 17, 2026

Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month

February 12, 2026

The U.S. EPA Announces New Registration for Low-Volatility Dicamba Herbicides

February 6, 2026

Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo

February 5, 2026

Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign

January 29, 2026

Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada

January 27, 2026

Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention

January 27, 2026

Legal notice to all canadians outside of Québec - notice of class action certification and settlement approval hearing

January 24, 2026

Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases

January 20, 2026

Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation

January 16, 2026

Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

January 14, 2026

Bayer Accelerates Pharma Growth on High-Value Portfolio

January 13, 2026

Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause

January 13, 2026

Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus

January 12, 2026

Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy

January 8, 2026

Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization

January 7, 2026

Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference

January 5, 2026

← Newer news releases

Calls in 2026

Decks in 2026